See how our technology creates Endless Possibilities
CEO in Your Corner
Deborah Moorad shares her insights on Nature Technology’s products and services, the industry and the future of genetic engineering.
DID YOU KNOW
cGMP Facilities Are Expanding to Meet Worldwide Increased Demand for Plasmid DNA Production
In light of the worldwide COVID-19 pandemic, as well as rapid advances in technology in other areas of plasmid based medicines, vaccines, and gene therapies, a worldwide bottleneck has been created due to the plasmid DNA supply chain.
DID YOU KNOW
CRO mergers are creating biotech “one-stop shops”
Four recent clinical research organization (CRO) acquisitions and mergers have indicated a growing trend among biotech manufacturing companies. Charles River acquired Cognate Bioservices, Catalent Paragon acquired Delphi, WuXi Advanced Therapies acquired Oxgene, and Wacker Biotech acquired Genopsis.
DID YOU KNOW
Nanoplasmid Enhances DNA Vaccines for Venezuelan Equine Encephalitis Virus and Ebola Virus
Nanoplasmid increases efficacy of DNA Vaccines for Venezuelan Equine Encephalitis Virus and Ebola Virus
CASE STUDY
See how Poseida Therapeutics is utilizing the “dual benefits” of our Nanoplasmid™ vector for success
Data from their ongoing Phase 1 expansion trial using Nanoplasmid demonstrated an improvement in efficacy over standard plasmid and a potentially best-in-class safety profile.
Our Twitter Feed
Happy Holidays from all of us at Nature Technology!
We will be closed on Friday December 24th and Friday December 31st. We wish you a wonderful, prosperous holiday season!